2018 Annual Equity Distribution Implementation Announcement
Release time:
2020-08-05
Securities Code: 600668 Securities abbreviation: Jianfeng Group Announcement No: 2019-026
Zhejiang Jianfeng Group Co., Ltd. Division
2018 Annual Equity Distribution Implementation Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents. |
Important Note:
l Distribution Ratio per Share
Cash Dividend per Share of A Shares 0.30 Yuan
l Relevant Date
Share Category |
Share Registration Date |
Last Trading Day |
ex-rights (interest) date |
cash dividend payment date |
a shares |
2019/7/17 |
- |
2019/7/18 |
2019/7/18 |
l Differentiated Dividend Transfer: no
1. Pass Distribution Plan Session and Date
This profit distribution plan was approved by the Company's 2018 Annual General Meeting on May 24, 2019.
2. Distribution Plan
1. Distribution Year: 2018 Year
2. Distribution Object:
As of the closing of Shanghai Stock Exchange in the afternoon of the equity registration date, all shareholders of the company registered in the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. (hereinafter referred to as "China Clearing Shanghai Branch").
3. Distribution Plan:
This profit distribution is based on 344,083,828 shares of the company's total share capital before the implementation of the plan, with a cash dividend of 0.30 yuan (including tax) per share, totaling 103,225,148.40 yuan.
3. Relevant Date
Share Class |
Share Registration Date |
Last Trading Date |
Ex-rights (Interest) Date |
Cash Dividend Payment Date |
A shares |
2019/7/17 |
- |
2019/7/18 |
2019/7/18 |
4. distribution implementation method
1. implementation method
except the company the shareholder Jinhua Tongji State-owned Assets Investment Co., Ltd. is directly issued by the Company, the dividends of other unrestricted tradable shares are entrusted to China Clearing Shanghai Branch through its capital clearing system to be distributed to shareholders who have registered after the closing of the Shanghai Stock Exchange on the equity registration date and have handled designated transactions on the members of the Shanghai Stock Exchange. Investors who have handled designated transactions can receive cash dividends at their designated securities business department on the dividend payment date. Shareholders' dividends that have not handled designated transactions are temporarily kept by China Clearing Shanghai Branch and will be distributed after the designated transactions are handled.
2. self-distributed object
The cash dividends of Jinhua Tongji State-owned Assets Investment Co., Ltd., a shareholder of the Company, are directly distributed by the Company.
3. Tax Deduction Description
(1) Cash dividends for natural person shareholders and securities investment funds holding the company's unrestricted tradable shares, in accordance with the relevant provisions of the Notice on Issues Relating to Differentiated Individual Income Tax Policies on Dividends and Bonuses of Listed Companies (No.101 [2015] of the Ministry of Finance) and the Notice on Issues Relating to the Implementation of Differentiated Individual Income Tax Policies on Dividends and Bonuses of Listed Companies (No.85 [2012] of the Ministry of Finance), if the holding period (the holding period refers to the duration from the date when an individual acquires the company's shares in the public offering and transfer market to the day before the transfer and delivery of the shares) is less than one month (including one month), the full amount of dividend income shall be included in the taxable income, and the actual tax burden shall be 20%; if the holding period is more than one month to one year (including one year), its dividend income is included in the taxable income at 50%, and the actual tax burden is 10%; if the holding period exceeds 1 year, the dividend income is temporarily exempt from personal income tax. The company does not withhold personal income tax for the time being. When it transfers its shares, Zhongdeng Shanghai Branch will calculate the tax payable according to its shareholding period, and the securities company and other share custodian institutions will deduct and pay Zhongdeng Shanghai Branch from its capital account. Zhongdeng Shanghai Branch will pay the company within 5 working days of the following month, and the company will report and pay the tax to the competent tax authority within the statutory reporting period of the month in which the month.
(2) for the cash dividends of qualified foreign institutional investors (QFII) holding shares of the company, according to the relevant provisions of the notice on issues related to the withholding of enterprise income tax on dividends, dividends and interest paid by Chinese resident enterprises to QFII (Guoshuihan [2009] No. 47) (hereinafter referred to as the "notice"), the company shall withhold and pay enterprise income tax at a tax rate of 10%, after tax deduction, the actual cash dividend per share is 0.27 yuan. If the relevant shareholder considers that the dividend income received by him is subject to any tax treaty (arrangement) treatment, the shareholder may, in accordance with the provisions of the Notice, apply to the competent tax authorities on his own initiative after the dividend has been received.
(3) For investors (including enterprises and individuals) on the Hong Kong Stock Exchange who invest in the Company's A- shares ("Shanghai Stock Connect"), their cash dividends will be distributed by the Company through Zhongdeng Shanghai Branch in RMB according to the account of the nominal holder of the shares, tax deduction is implemented in accordance with the Notice of the Ministry of Finance, the State Administration of Taxation and the China Securities Regulatory Commission on the Relevant Tax Policies for the Pilot Interconnection Mechanism of Shanghai and Hong Kong Stock Market Transactions (Caishui [2014] No. 81), and the tax rate is 10%. The actual cash dividend per share is RMB 0.27.
(4) For company shareholders (including institutional investors) who belong to the meaning of resident enterprises under the "Enterprise Income Tax Law", their income tax is paid by themselves, and the actual cash dividend is RMB 0.30 per share.
5. Relevant Consultation Methods
If you have any questions about the company's equity distribution, please contact us through the following contact information.
Contact Department: Jianfeng Group Board Office
Tel: 0579-82324699
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
July 12, 2019
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31